Ren Bei Chen - Net Worth and Insider Trading
Ren Bei Chen Net Worth
The estimated net worth of Ren Bei Chen is at least $6 Million dollars as of 2024-11-08. Ren Bei Chen is the Supervisors of Tibet Rhodiola Pharmaceutical Holding Co and owns about 160,160 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) stock worth over $6 Million. Details can be seen in Ren Bei Chen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ren Bei Chen has not made any transactions after 2008-01-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ren Bei Chen
Ren Bei Chen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ren Bei Chen owns 1 companies in total, including Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) .
Click here to see the complete history of Ren Bei Chen’s form 4 insider trades.
Insider Ownership Summary of Ren Bei Chen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | Supervisors |
Ren Bei Chen Latest Holdings Summary
Ren Bei Chen currently owns a total of 1 stock. Ren Bei Chen owns 160,160 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) as of January 25, 2008, with a value of $6 Million.
Latest Holdings of Ren Bei Chen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | 160,160 | 40.14 | 6,428,822 |
Holding Weightings of Ren Bei Chen
Ren Bei Chen Form 4 Trading Tracker
According to the SEC Form 4 filings, Ren Bei Chen has made a total of 0 transactions in Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) over the past 5 years. The most-recent trade in Tibet Rhodiola Pharmaceutical Holding Co is the sale of 160,160 shares on January 25, 2008, which brought Ren Bei Chen around $445,760.
Insider Trading History of Ren Bei Chen
- 1
Ren Bei Chen Trading Performance
GuruFocus tracks the stock performance after each of Ren Bei Chen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ren Bei Chen is -40%. GuruFocus also compares Ren Bei Chen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ren Bei Chen within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ren Bei Chen's insider trading performs compared to the benchmark.
Performance of Ren Bei Chen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.85 | | | | | |
| Relative Return to S&P 500(%) | 2.75 | | | | | |
Ren Bei Chen Ownership Network
Ownership Network List of Ren Bei Chen
Ownership Network Relation of Ren Bei Chen
Ren Bei Chen Owned Company Details
What does Tibet Rhodiola Pharmaceutical Holding Co do?
Who are the key executives at Tibet Rhodiola Pharmaceutical Holding Co?
Ren Bei Chen is the Supervisors of Tibet Rhodiola Pharmaceutical Holding Co. Other key executives at Tibet Rhodiola Pharmaceutical Holding Co include senior management Wang Bao Ming , senior management Cao Shu Zhen , and Supervisors Liu De Gong .
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tibet Rhodiola Pharmaceutical Holding Co Insider Transactions
Ren Bei Chen Mailing Address
Above is the net worth, insider trading, and ownership report for Ren Bei Chen. Currently GuruFocus does not have mailing address information for Ren Bei Chen.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
